Search Results - "Heimans, J. J."

Refine Results
  1. 1

    The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial by Boele, Florien W, Douw, Linda, de Groot, Marjolein, van Thuijl, Hinke F, Cleijne, Wilmy, Heimans, Jan J, Taphoorn, Martin J B, Reijneveld, Jaap C, Klein, Martin

    Published in Neuro-oncology (Charlottesville, Va.) (01-10-2013)
    “…Fatigue, cognitive deficits, and depression are frequently reported but often undertreated symptoms that can profoundly affect daily life in patients with…”
    Get full text
    Journal Article
  2. 2

    Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment by DE GROOT, Marjolein, REIJNEVELD, Jaap C, ARONICA, Eleonora, HEIMANS, Jan J

    Published in Brain (London, England : 1878) (01-04-2012)
    “…Brain tumours frequently cause epileptic seizures. Medical antiepileptic treatment is often met with limited success. Pharmacoresistance, drug interactions and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Symptoms and problems in the end-of-life phase of high-grade glioma patients by Sizoo, Eefje M., Braam, Lies, Postma, Tjeerd J., Pasman, H. Roeline W., Heimans, Jan J., Klein, Martin, Reijneveld, Jaap C., Taphoorn, Martin J. B.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2010)
    “…Despite multimodal treatment, it is not possible to cure high-grade glioma (HGG) patients. Therefore, the aim of treatment is not only to prolong life, but…”
    Get full text
    Journal Article
  5. 5

    The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20 by Postma, T.J., Aaronson, N.K., Heimans, J.J., Muller, M.J., Hildebrand, J.G., Delattre, J.Y., Hoang-Xuan, K., Lantéri-Minet, M., Grant, R., Huddart, R., Moynihan, C., Maher, J., Lucey, R.

    Published in European journal of cancer (1990) (01-05-2005)
    “…Chemotherapy-induced peripheral neuropathy (CIPN) is a common phenomenon, often resulting in serious limitations in daily functioning and comprosised quality…”
    Get full text
    Journal Article
  6. 6

    Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma by AARONSON, Neil K, TAPHOORN, Martin J. B, HEIMANS, Jan J, POSTMA, Tjeerd J, GUNDY, Chad M, BEUTE, Guus N, SLOTMAN, Ben J, KLEIN, Martin

    Published in Journal of clinical oncology (20-11-2011)
    “…To investigate the generic and condition-specific health-related quality of life (HRQL) of patients with low-grade glioma (LGG). A total of 195 patients with…”
    Get full text
    Journal Article
  7. 7

    'Functional connectivity' is a sensitive predictor of epilepsy diagnosis after the first seizure by Douw, Linda, de Groot, Marjolein, van Dellen, Edwin, Heimans, Jan J, Ronner, Hanneke E, Stam, Cornelis J, Reijneveld, Jaap C

    Published in PloS one (26-05-2010)
    “…Although epilepsy affects almost 1% of the world population, diagnosis of this debilitating disease is still difficult. The EEG is an important tool for…”
    Get full text
    Journal Article
  8. 8

    Long-term effects of temporal lobe epilepsy on local neural networks: a graph theoretical analysis of corticography recordings by van Dellen, Edwin, Douw, Linda, Baayen, Johannes C, Heimans, Jan J, Ponten, Sophie C, Vandertop, W Peter, Velis, Demetrios N, Stam, Cornelis J, Reijneveld, Jaap C

    Published in PloS one (26-11-2009)
    “…Pharmaco-resistant temporal lobe epilepsy (TLE) is often treated with surgical intervention at some point. As epilepsy surgery is considered a last resort by…”
    Get full text
    Journal Article
  9. 9

    Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma by DE GROOT, M, ARONICA, E, HEIMANS, J. J, REIJNEVELD, J. C

    Published in Neurology (09-08-2011)
    “…To correlate SV2A expression in surgically removed tumor and peritumoral tissue of glioma patients with epilepsy with the clinical response to levetiracetam in…”
    Get full text
    Journal Article
  10. 10

    Symptoms and medication management in the end of life phase of high-grade glioma patients by Koekkoek, J. A. F., Dirven, L., Sizoo, E. M., Pasman, H. R. W., Heimans, J. J., Postma, T. J., Deliens, L., Grant, R., McNamara, S., Stockhammer, G., Medicus, E., Taphoorn, M. J. B., Reijneveld, J. C.

    Published in Journal of neuro-oncology (01-12-2014)
    “…During the end of life (EOL) phase of high-grade glioma (HGG) patients, care is primarily aimed at reducing symptom burden while maintaining quality of life as…”
    Get full text
    Journal Article
  11. 11

    Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review by Koekkoek, Johan A F, Kerkhof, Melissa, Dirven, Linda, Heimans, Jan J, Reijneveld, Jaap C, Taphoorn, Martin J B

    Published in Neuro-oncology (Charlottesville, Va.) (01-07-2015)
    “…There is growing evidence that antitumor treatment contributes to better seizure control in low-grade glioma patients. We performed a systematic review of the…”
    Get full text
    Journal Article
  12. 12

    Local polymorphic delta activity in cortical lesions causes global decreases in functional connectivity by van Dellen, E., Hillebrand, A., Douw, L., Heimans, J.J., Reijneveld, J.C., Stam, C.J.

    Published in NeuroImage (Orlando, Fla.) (01-12-2013)
    “…Increasing evidence from neuroimaging and modeling studies suggests that local lesions can give rise to global network changes in the human brain. These…”
    Get full text
    Journal Article
  13. 13
  14. 14

    End of life care in high-grade glioma patients in three European countries: a comparative study by Koekkoek, J. A. F., Dirven, L., Reijneveld, J. C., Sizoo, E. M., Pasman, H. R. W., Postma, T. J., Deliens, L., Grant, R., McNamara, S., Grisold, W., Medicus, E., Stockhammer, G., Oberndorfer, S., Flechl, B., Marosi, C., Taphoorn, M. J. B., Heimans, J. J.

    Published in Journal of neuro-oncology (01-11-2014)
    “…Exploring cross-national differences is useful to evaluate whether different patterns of end of life (EOL) care meet patient’s specific needs. This study aimed…”
    Get full text
    Journal Article
  15. 15

    Neurotoxic complications of chemotherapy in patients with cancer: Clinical signs and optimal management by VERSTAPPEN, Carla C. P, HEIMANS, Jan J, HOEKMAN, Klaas, POSTMA, Tjeerd J

    Published in Drugs (New York, N.Y.) (01-01-2003)
    “…Neurotoxic side effects of chemotherapy occur frequently and are often a reason to limit the dose of chemotherapy. Since bone marrow toxicity, as the major…”
    Get full text
    Journal Article
  16. 16

    Decision-making in the end-of-life phase of high-grade glioma patients by Sizoo, Eefje M, Pasman, H. Roeline W, Buttolo, Janine, Heimans, Jan J, Klein, Martin, Deliens, Luc, Reijneveld, Jaap C, Taphoorn, Martin J.B

    Published in European journal of cancer (1990) (01-01-2012)
    “…Abstract Background During the disease course of high-grade glioma (HGG) patients, the goal of therapy eventually shifts from primarily life-prolongation to…”
    Get full text
    Journal Article
  17. 17

    Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide by Koekkoek, Johan A F, Dirven, Linda, Heimans, Jan J, Postma, Tjeerd J, Vos, Maaike J, Reijneveld, Jaap C, Taphoorn, Martin J B

    “…Background Seizures are a common symptom in patients with low-grade glioma (LGG), negatively influencing quality of life, if uncontrolled. Besides…”
    Get full text
    Journal Article
  18. 18

    Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients by Ediebah, Divine E., Reijneveld, Jaap C., Taphoorn, Martin J. B., Coens, Corneel, Zikos, Efstathios, Aaronson, Neil K., Heimans, Jan J., Bottomley, Andrew, Klein, Martin

    Published in Quality of life research (01-04-2017)
    “…Purpose Clinical trials in glioma patients with neurocognitive deficits face challenges due to lacking or unreliable patient self-reports on their…”
    Get full text
    Journal Article
  19. 19

    The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study by Boogerd, W., van den Bent, M.J., Koehler, P.J., Heimans, J.J., van der Sande, J.J., Aaronson, N.K., Hart, A.A.M., Benraadt, J., Vecht, Ch.J.

    Published in European journal of cancer (1990) (01-12-2004)
    “…To assess the benefit of intraventricular chemotherapy, patients with leptomeningeal metastasis (LM) from breast cancer were randomised to treatment including…”
    Get full text
    Journal Article
  20. 20

    Local MEG networks: The missing link between protein expression and epilepsy in glioma patients? by Douw, L., de Groot, M., van Dellen, E., Aronica, E., Heimans, J.J., Klein, M., Stam, C.J., Reijneveld, J.C., Hillebrand, A.

    Published in NeuroImage (Orlando, Fla.) (15-07-2013)
    “…Connectivity and network analysis in neuroscience has been applied to multiple spatial scales, but the links between these different scales have rarely been…”
    Get full text
    Journal Article